Navigation Links
National Institutes of Health grant to fund drug abuse research at UH
Date:11/28/2007

A center dedicated to building the multidisciplinary drug abuse research capacity of the University of Houston is the focus of a five-year, $2.3 million grant awarded to the Graduate College of Social Works Office of Drug and Social Policy Research (ODSPR).

Funding for the initiative comes from the National Institute on Drug Abuse (NIDA), which is part of the National Institutes for Health (NIH). The funds will support the creation of the Minority Institutions Drug Abuse Research Development Program (DARDP) at UH.

The emphasis of the DARDP is to train and mentor faculty and graduate students on the health and social consequences of drug abuse among aging minority populations and address drug abuse prevention, intervention and service research, said Avelardo Valdez, director of the ODSPR and principal investigator of the initiative. The institute will address drug use within the context of other related social and health problems confronting aging Latino injecting heroin users, and will contribute to improving the health of this population in the Houston area.

Focusing on developing research projects, the DARDP will collaborate with the UH Graduate College of Social Work, the Office for Drug and Social Policy Research, the Department of Sociology and other drug treatment organizations in the Houston area. In addition, the grant will fund two studies on Latino heroin use, workshops, seminars and small grants for faculty and students, and establish a peer-review ad-hoc committee that will oversee drafts of publications of new investigators.

Substance abuse is a serious problem in the Latino community, Valdez said. There are serious health and social consequences, such as the spread of HIV/AIDS and other blood-borne pathogens. To minimize this, we need a better understanding of the addict and addiction. Our purpose is to build more knowledge and put that knowledge into practice.

A pair of studies will focus on the heroin use of aging Latino men in Houstons near Northside and East End communities, where, Valdez says, there is a high rate of heroin use among Latinos. The first will study 225 users and look into the consequences of the addiction on their lifes path, long-term health implications and community and family support. The second study will focus on the role social networks, such as family and peers, play in a lifetime of heroine use. Both studies will investigate current users, those who are in treatment and those who are not in treatment. The overall objective is to develop the capacity of UH faculty to compete for external funding, particularly at the NIH level.


'/>"/>

Contact: Marisa Ramirez
mrcannon@uh.edu
713-743-8152
University of Houston  
Source:Eurekalert

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Yakima Health Care Leader Tapped for Leadership Post at National Association
3. Virginia Tech Report Has National Importance
4. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
8. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. LCA Hails International Investigators Studying Lung Cancer
11. National Patient Safety Foundation Partners with Vocera Communications
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
National Institutes of Health grant to fund drug abuse research at UH
(Date:3/29/2017)... Yorba Linda, Ca (PRWEB) , ... March 29, ... ... a standard process in many scientific laboratories. The assembly protocols involve many repetitive ... is well suited for automation, which enables the high-throughput needed, and results in ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Wharton School of the University of Pennsylvania ... have made a $10 million gift to establish the Ken Moelis and Julie ... pathway to a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests ...
(Date:3/28/2017)... ... March 28, 2017 , ... For many women, getting birth control isn’t as easy as ... they either don’t have access to a health care facility or a pharmacy within 60 ... of the United States or for many who are faced with health or personal issues ...
(Date:3/28/2017)... ... ... The Thyroid Secret is a specialized 9-part documentary series ... recently launched on March 1, and Dr. Wentz discussed varied benefits and aspects ... Wentz is a licensed pharmacist and a foremost thyroid specialist. After being diagnosed ...
(Date:3/28/2017)... ... March 28, 2017 , ... Via Oncology, the leading provider ... a free, public-facing tool for analyzing the costs of various drug regimens in ... information to patients, providers, insurers and pharmaceutical companies about the estimated costs of ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TAIPEI, Taiwan , March 28, 2017 /PRNewswire/ ... medical device company, is pleased to announce ... Series A investment of Panther Orthopedics, Inc., a ... pioneering innovative dynamic fixation solutions for orthopedic extremity ... market continues to expand rapidly, primarily due to ...
(Date:3/28/2017)...  "US Cancer Generics Market Outlook 2022" report ... trend analysis related to the emergence and integration ... in US. The report analyzes various clinical and ... generics drugs in recent years. The introduction of ... dollars for various stake holders involved US cancer ...
(Date:3/28/2017)... -- Orexigen Therapeutics, Inc. (Nasdaq: OREX ) today ... and year ended December 31, 2016. ... Orexigen, beginning with the re-acquisition of the rights to ... team at Orexigen demonstrated remarkable focus, executing on a ... our Company while rewarding us full control of our ...
Breaking Medicine Technology: